Bridgewater Associates’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,918	Closed	-$154K	–	868
2022 Q2	$154K	Buy	10,918 +1,929	+21%	+$27.2K	﹤0.01%	978
2022 Q1	$218K	Buy	+8,989	New	+$218K	﹤0.01%	957